Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Judith M. Versluis"'
Autor:
Annegien Broeks, Michel W J M Wouters, Georgina V Long, Richard A Scolyer, Christian U Blank, Judith M Versluis, Karijn P M Suijkerbuijk, Petros Dimitriadis, Joyce Sanders, James S Wilmott, Alexander Maxwell Menzies, Yvonne M Schrage, Stephanie A Blankenstein, Robert Elens, Willeke A M Blokx, Winan van Houdt, Alexander C J van Akkooi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 4 (2024)
Background A substantial proportion of patients with macroscopic stage III melanoma do not benefit sufficiently from adjuvant anti-PD-1 therapy, as they either recur despite therapy or would never have recurred. To better inform adjuvant treatment se
Externí odkaz:
https://doaj.org/article/e0b90991b4304091afe1ffd233fc064c
Autor:
Annegien Broeks, Sofie Wilgenhof, John B A G Haanen, Karolina Sikorska, Christian U Blank, Judith M Versluis, Jan Willem B de Groot, Esmee P Hoefsmit, Elisa A Rozeman, Petros Dimitriadis, Aysegul Sari, Daan van den Broek, Disha Rao, Ruben Lacroix, Lindsay G Grijpink-Ongering, Marta Lopez-Yurda, Birthe C Heeres, Bart A van de Wiel, Claudie Flohil, Stijn W T P J Heijmink, Marieke A Vollebergh, Johannes V van Thienen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 7 (2023)
Background Continuous combination of MAPK pathway inhibition (MAPKi) and anti-programmed death-(ligand) 1 (PD-(L)1) showed high response rates, but only limited improvement in progression-free survival (PFS) at the cost of a high frequency of treatme
Externí odkaz:
https://doaj.org/article/85f4bb454d4548b7b0eddc4aff9da5e2
Autor:
Leonie Müller-Jensen, Sarah Zierold, Judith M Versluis, Wolfgang Boehmerle, Petra Huehnchen, Matthias Endres, Raphael Mohr, Annette Compter, Christian U Blank, Tim Hagenacker, Friedegund Meier, Lydia Reinhardt, Anja Gesierich, Martin Salzmann, Jessica C Hassel, Selma Ugurel, Lisa Zimmer, Patricia Banks, Lavinia Spain, Jennifer A Soon, Tomohiro Enokida, Makoto Tahara, Katharina C Kähler, Ruth Seggewiss-Bernhardt, Catriona Harvey, Georgina V Long, Florian Schöberl, Louisa von Baumgarten, Thomas Hundsberger, Max Schlaak, Lars E French, Samuel Knauss, Lucie M Heinzerling
Publikováno v:
Data in Brief, Vol 45, Iss , Pp 108649- (2022)
Over the past decade, cancer immunotherapy with immune checkpoint inhibitors (ICIs) has significantly improved the outcome of many malignancies. However, with the broad use of ICIs, neurological immune related adverse events (irAE) are increasingly r
Externí odkaz:
https://doaj.org/article/c91a9542a832459593f5a6f29e793e54
Autor:
Bart Neyns, Lisa Zimmer, Caroline Robert, Celeste Lebbe, Olivier Michielin, Omid Hamid, Anne Zaremba, Oliver Klein, Ruth Plummer, Joanna Mangana, Paolo A Ascierto, Katharina C Kähler, Georgina V Long, Ryan Sullivan, Grant A McArthur, Michael Weichenthal, Egle Ramelyte, Meghan J Mooradian, Douglas B Johnson, Alexander Shoushtari, Christian U Blank, Judith M Versluis, Prachi Bhave, Claudia Trojanello, Lu Si, Inderjit Mehmi, Tasnia Ahmed, Alexander M Menzies, Adnan Khattak, Severine Roy, Matteo S Carlino, Paul C Lorigan, Clara Allayous, Rachel Roberts-Thomson, Florentia Dimitriou, Kathleen Batty, Thierry Lesimple, Serigne N Lo, Alexandre Wicky, Richard Heywood, Lena Tran, Anna Stansfeld, Julia K Schwarze, Andrea Maurichi, Hui-Ling Yeoh, Mario Santinami, Andrew M Haydon
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 7 (2022)
Background Acral melanoma is a rare melanoma subtype with poor prognosis. Importantly, these patients were not identified as a specific subgroup in the landmark melanoma trials involving ipilimumab and the anti-programmed cell death protein-1 (PD-1)
Externí odkaz:
https://doaj.org/article/0b1c2b670e1e4ec1b95b97b6b085c47b
Publikováno v:
Nature Reviews Clinical Oncology. 20:408-422
Autor:
Patricio Serra-Bellver, Judith M. Versluis, Honey K. Oberoi, Cong Zhou, Timothy D. Slattery, Yasir Khan, James R. Patrinely, Inês Pires da Silva, C. Martínez-Vila, Natalie Cook, Donna M. Graham, Matteo S. Carlino, Alexander M. Menzies, Ana M. Arance, Douglas B. Johnson, Georgina V. Long, Lisa Pickering, James M.G. Larkin, Christian U. Blank, Paul Lorigan
Publikováno v:
European Journal of Cancer. 176:121-132
To assess efficacy and toxicity of combination immunotherapy with ipilimumab plus nivolumab in routine practice in a retrospective multicentre cohort of patients with advanced melanoma.This retrospective analysis included patients with advanced melan
Autor:
Judith M Versluis, Daniela S Thommen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Neoadjuvant chemo(radio)therapy is part of the established standard of care in cancer treatment; neoadjuvant application of immunotherapy, however, is only performed within recent trials. Combination of programmed cell death protein 1 and cytotoxic T
Externí odkaz:
https://doaj.org/article/002ea29c4ad24282a7491ed9f244c524
Autor:
Judith M Versluis, Daniela S Thommen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Externí odkaz:
https://doaj.org/article/e1b734a6831e4063891c6694075f85e9
Autor:
Christian U. Blank, Maarten Altelaar, Reinhard Dummer, Dirk Schadendorf, Georgina V. Long, Alexander C.J. van Akkooi, Liesbeth Hoekman, Judith M. Versluis, Irene L.M. Reijers, Elisa A. Rozeman, Franziska Völlmy, Esmee P. Hoefsmit
Figure S5 shows that complement factor B (CFB), component 7 (C7) and alpha-1B-glycoportein (A1BG) expression are increased upon melanoma progression and recurrence.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eff2f8a8ef3578e8d03ed12f2d2bff3
https://doi.org/10.1158/2767-9764.22546879.v1
https://doi.org/10.1158/2767-9764.22546879.v1
Autor:
Christian U. Blank, Maarten Altelaar, Reinhard Dummer, Dirk Schadendorf, Georgina V. Long, Alexander C. J. van Akkooi, Liesbeth Hoekman, Judith M. Versluis, Irene L. M. Reijers, Elisa A. Rozeman, Franziska Völlmy, Esmee P. Hoefsmit
Table S2 shows the patient characteristics OpACIN-neo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d3d766be71944993e367996d02533fa
https://doi.org/10.1158/2767-9764.22546870.v1
https://doi.org/10.1158/2767-9764.22546870.v1